262 related articles for article (PubMed ID: 24144799)
1. Inhibitory effects of celastrol on rat liver cytochrome P450 1A2, 2C11, 2D6, 2E1 and 3A2 activity.
Sun M; Tang Y; Ding T; Liu M; Wang X
Fitoterapia; 2014 Jan; 92():1-8. PubMed ID: 24144799
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory mechanisms of celastrol on human liver cytochrome P450 1A2, 2C19, 2D6, 2E1 and 3A4.
Jin C; He X; Zhang F; He L; Chen J; Wang L; An L; Fan Y
Xenobiotica; 2015; 45(7):571-7. PubMed ID: 25811791
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Mechanisms of Myricetin on Human and Rat Liver Cytochrome P450 Enzymes.
Lou D; Bao SS; Li YH; Lin QM; Yang SF; He JY
Eur J Drug Metab Pharmacokinet; 2019 Oct; 44(5):611-618. PubMed ID: 30825074
[TBL] [Abstract][Full Text] [Related]
4. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms.
Or PM; Lam FF; Kwan YW; Cho CH; Lau CP; Yu H; Lin G; Lau CB; Fung KP; Leung PC; Yeung JH
Phytomedicine; 2012 Apr; 19(6):535-44. PubMed ID: 22261394
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cytochrome P450 inhibition and induction potential of lupeol and betulin in rat liver microsomes.
Seervi M; Lotankar S; Barbar S; Sathaye S
Drug Metab Pers Ther; 2016 Jun; 31(2):115-22. PubMed ID: 26959552
[TBL] [Abstract][Full Text] [Related]
6. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
Eagling VA; Tjia JF; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
[TBL] [Abstract][Full Text] [Related]
8. Enzyme kinetic and molecular docking studies on the metabolic interactions of 1-hydroxy-2,3,5-trimethoxy-xanthone, isolated from Halenia elliptica D. Don, with model probe substrates of human cytochrome P450 enzymes.
Feng R; Zhou X; Or PM; Ma JY; Tan XS; Fu J; Ma C; Shi JG; Che CT; Wang Y; Yeung JH
Phytomedicine; 2012 Sep; 19(12):1125-33. PubMed ID: 22819301
[TBL] [Abstract][Full Text] [Related]
9. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats.
Wang B; Yang S; Hu J; Li Y
J Ethnopharmacol; 2014 Sep; 155(3):1473-82. PubMed ID: 25091466
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharide peptides from Coriolus versicolor competitively inhibit model cytochrome P450 enzyme probe substrates metabolism in human liver microsomes.
Yeung JH; Or PM
Phytomedicine; 2012 Mar; 19(5):457-63. PubMed ID: 22305191
[TBL] [Abstract][Full Text] [Related]
11. Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro.
Wang X; Cheung CM; Lee WY; Or PM; Yeung JH
Phytomedicine; 2010 Sep; 17(11):868-75. PubMed ID: 20638257
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the impact of 16-dehydropregnenolone on the activity and expression of rat hepatic cytochrome P450 enzymes.
Ramakrishna R; Bhateria M; Singh R; Bhatta RS
J Steroid Biochem Mol Biol; 2016 Oct; 163():183-92. PubMed ID: 27224941
[TBL] [Abstract][Full Text] [Related]
13. Effect of recombinant human thymosin-alpha1, an immuno-modulating peptide with 28 amino acids, on the activity of cytochrome P450s.
Wang B; He F; Lin Y; Huang M; Zhou SF
Drug Metab Lett; 2007 Aug; 1(3):199-204. PubMed ID: 19356044
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of acacetin inhibition potential against cytochrome P450 in vitro and in vivo.
Zhou Y; Tu Y; Zhou Q; Hua A; Geng P; Chen F; Han A; Liu J; Dai D; Wang S; Wang J; Wen C
Chem Biol Interact; 2020 Sep; 329():109147. PubMed ID: 32738202
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
Wei J; Zhang H; Zhao Q
Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
Kobayashi K; Urashima K; Shimada N; Chiba K
Biochem Pharmacol; 2002 Mar; 63(5):889-96. PubMed ID: 11911841
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of the main metabolites of Apatinib on CYP450 isozymes in human and rat liver microsomes.
Pang NH; Xu RA; Chen LG; Chen Z; Hu GX; Zhang BW
Toxicol In Vitro; 2024 Mar; 95():105739. PubMed ID: 38042355
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
[TBL] [Abstract][Full Text] [Related]
19. Investigation of cytochrome P450 inhibitory properties of maslinic acid, a bioactive compound from Olea europaea L., and its structure-activity relationship.
Sun M; Tang Y; Ding T; Liu M; Wang X
Phytomedicine; 2015 Jan; 22(1):56-65. PubMed ID: 25636872
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
